Understanding Cell Communication and Tissue Memory in Vitiligo
Official title: Cell-Cell Communications and Tissue Memory in Vitiligo
Funded at Univ of Massachusetts Med Sch Worcester · NIH-11159473 · Data updated 2026-11-12
This project aims to understand how skin cells communicate and remember past events in people with vitiligo, hoping to find new ways to treat the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project start | September 12, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $453,810 |
| NIH project number | 5P50AR080593-04 |
| Project ID | NIH-11159473 on NIH RePORTER |
Who could benefit from this research
✓Could help
This foundational research is for future patients with vitiligo, as it seeks to uncover new biological targets for treatment rather than directly recruiting participants now.
✕Less likely to help
Patients seeking immediate treatment or direct participation in a clinical trial would not directly benefit from this early-stage basic science project.
What this research studies
Vitiligo is an autoimmune skin condition where the body's immune cells mistakenly attack pigment-making cells, leading to white patches. Our team is looking closely at how cells in the skin talk to each other, both through secreted molecules and direct contact, and how these conversations go wrong in vitiligo. We use advanced techniques like single-cell RNA sequencing to create detailed maps of these cell communications, identifying hundreds of signaling molecules that are different in affected skin. By understanding these complex signals and how they create a 'memory' of the disease, we hope to uncover the root causes of vitiligo progression. This work is crucial for developing more effective treatments that target the specific ways vitiligo develops and persists.
Why it matters
Potential benefit: If successful, this work could lead to the development of new and more effective treatments for vitiligo by targeting the specific cell communication pathways that drive the disease.
How similar studies have gone: While the specific approach of mapping cell communications in vitiligo at this level of detail is novel, it builds upon existing knowledge of autoimmune disease mechanisms and cell signaling pathways.
Where this research is happening
-
Univ of Massachusetts Med Sch Worcester
Worcester, United States Active
Researchers
- Principal investigator: Garber, Manuel — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Garber, Manuel
Related research
Other NIH-funded projects on the same topics.
-
Cell communications and tissue memory in vitiligo
This grant looks at how skin cells talk to each other and how these conversations may drive vitiligo, with the goal of finding new ways to treat or manage the condition.
-
Autoreactive T Cell Function in Vitiligo
A study in people with vitiligo and related models aims to understand how skin-homing T cells drive pigment loss and how this knowledge could lead to better treatments.
-
Understanding why the immune system targets skin in vitiligo and how this causes lasting damage
A research program is studying how immune cells attack pigment cells in the skin of people with vitiligo and what drives this autoimmune process.
-
Understanding why some vitiligo patches repigment while others stay white
This grant studies why certain vitiligo patches repigment in some areas after treatment and why others persist, aiming to make treatments faster and more even.
-
Understanding T Cells in Vitiligo
This research explores how certain immune cells, called T cells, cause the skin condition vitiligo, which leads to white spots on the skin.
-
Understanding Autoimmunity in Vitiligo
This project aims to understand how the immune system attacks skin cells in people with vitiligo, causing white patches.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.